Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Rishi S. Mehta"'
Publikováno v:
Clinical and Translational Science, Vol 15, Iss 1, Pp 63-69 (2022)
Abstract Low‐dose methotrexate (MTX) is an immunosuppressant used to treat inflammatory bowel disease (IBD). SLCO1B1 genetic variation has been associated with delayed MTX clearance and increased toxicity. The purpose of this study was to evaluate
Externí odkaz:
https://doaj.org/article/7312e4e443344c46acccaabfd37284d5
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 15, Iss 1, Pp 63-69 (2022)
Clinical and Translational Science, Vol 15, Iss 1, Pp 63-69 (2022)
Low‐dose methotrexate (MTX) is an immunosuppressant used to treat inflammatory bowel disease (IBD). SLCO1B1 genetic variation has been associated with delayed MTX clearance and increased toxicity. The purpose of this study was to evaluate the assoc
Publikováno v:
The FASEB Journal. 34:1-1